BillionToOne Share Price

BillionToOne Share Price

NASDAQ: BLLN | Small Cap | Healthcare
$91.50
-$6.02 (-6.17%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

BillionToOne Stock Performance

Open
$93.05
Prev. Close
$97.51
Circuit Range
N/A
Day Range
$85.79 - $94.51
Year Range
$62.08 - $150.35
Volume
85,636
Average Traded
$91.39

BillionToOne Share Price Today

As of 19 November 2026, BillionToOne, Inc. Class A's share price is $91.50. The stock opened at $93.05, compared to its previous close of $97.51. During today's trading session, BillionToOne, Inc. Class A's share price traded between $85.79 and $94.51, with an average price of $90.15. Over the past 52 weeks, the stock has recorded a high of $150.35 and a low of $62.08. In terms of performance, BillionToOne, Inc. Class A's share price has declined by 7.43% over the last six months and is down 29.62% on a year-on-year basis.

BillionToOne Share Price Chart

Line chart of the BillionToOne price trend over the selected period. The price fell overall, ranging from 85.79 to 94.50, ending at 91.50.
$85.79$94.51
L
Show Current Price
H

BillionToOne Stock Fundamentals & Key Indicators

Market Cap
$1.45B
PE Ratio (TTM)
101.38
Dividend Yield
0.00%
EPS (TTM)
$0.96
Revenue (TTM)
$305.11B
Return On Equity (TTM)
8.11%
Profit Margin
0.96%
Debt to Equity
0.16
Quarterly Earnings Growth YoY
587.35%

BillionToOne Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$96.05$108.39$109.45$122.98
Net Profit$2.53$17.97$8.05$17.39
Net Profit Margin2.63%16.58%7.35%14.14%
Income ChangeN/A610.28%-55.20%116.02%

BillionToOne Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$305.11
Net Profit$2.92
Net Profit Margin0.96%
Income ChangeN/A

BillionToOne Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets72.1
Current Assets560.56
Total Assets632.65
Non Current Liabilities104.59
Current Liabilities47.96
Total Liabilities152.55
Shareholders' Equity480.11

BillionToOne Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating24.6
Investing-8.92
Financing288.83

About BillionToOne

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

BillionToOne Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$112.79
$91.39
-19.33%
Oct 2026
$107.47
$113.29
+6.54%
Sep 2026
$92.14
$106.33
+11.84%
Aug 2026
$137.38
$95.08
-31.38%
Jul 2026
$119.91
$138.56
+15.62%
Jun 2026
$95.24
$119.84
+21.25%
May 2026
$73.77
$98.84
+31.76%
Apr 2026
$77.64
$75.02
-4.56%
Mar 2026
$75.50
$78.60
+3.26%
Feb 2026
$85.11
$76.12
-7.85%
Jan 2026
$86.89
$82.60
+0.81%
Dec 2025
$126.25
$81.94
-36.97%

BillionToOne Share Price FAQs